| Attribute |
Value |
| 52 Week Change |
-0.9970687 |
| Address1 |
1,167 Massachusetts Avenue |
| All Time High |
66,875.0 |
| All Time Low |
0.115 |
| Ask |
0.274 |
| Ask Size |
1 |
| Average Daily Volume10 Day |
750,210 |
| Average Daily Volume3 Month |
1,494,798 |
| Average Volume |
1,494,798 |
| Average Volume10Days |
750,210 |
| Beta |
-2.409 |
| Bid |
0.1731 |
| Bid Size |
1 |
| Book Value |
0.468 |
| City |
Arlington |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.1922 |
| Current Ratio |
6.88 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
0.2051 |
| Day Low |
0.172 |
| Display Name |
KALA BIO |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,754,656,200 |
| Earnings Timestamp Start |
1,754,310,600 |
| Ebitda |
-24,068,500 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
0.146 |
| Enterprise Value |
-3,511,893 |
| Eps Forward |
-6.67 |
| Eps Trailing Twelve Months |
-10.71 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
0.58764 |
| Fifty Day Average Change |
-0.39543998 |
| Fifty Day Average Change Percent |
-0.672929 |
| Fifty Two Week Change Percent |
-99.70687 |
| Fifty Two Week High |
95.5 |
| Fifty Two Week High Change |
-95.3078 |
| Fifty Two Week High Change Percent |
-0.99798745 |
| Fifty Two Week Low |
0.115 |
| Fifty Two Week Low Change |
0.0772 |
| Fifty Two Week Low Change Percent |
0.67130435 |
| Fifty Two Week Range |
0.115 - 95.5 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,500,557,400,000 |
| Float Shares |
19,338,819 |
| Forward Eps |
-6.67 |
| Forward P E |
-0.028815592 |
| Free Cashflow |
-18,415,624 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
6 |
| Fullday Change |
0.0076000094 |
| Fullday Change Percent |
3.950109 |
| Fullday Price |
0.2 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.012410001 |
| Held Percent Institutions |
0.040710002 |
| Implied Shares Outstanding |
19,339,786 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,778,457,600 |
| Last Split Factor |
1:50 |
| Long Business Summary |
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. |
| Long Name |
KALA BIO, Inc. |
| Market |
us_market |
| Market Cap |
3,717,107 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_83652421 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-16 |
| Net Income To Common |
-10,080,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
10,830,280 |
| Open |
0.1903 |
| Operating Cashflow |
-19,863,000 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
781 996 5252 |
| Pre Market Change |
0.0076000094 |
| Pre Market Change Percent |
3.950109 |
| Pre Market Price |
0.2 |
| Pre Market Time |
1,792,150,966 |
| Prev Name |
Kala Pharmaceuticals, Inc. |
| Previous Close |
0.1928 |
| Price Hint |
4 |
| Price To Book |
0.41068378 |
| Profit Margins |
0.0 |
| Quick Ratio |
4.839 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.00059999526 |
| Regular Market Change Percent |
-0.31120086 |
| Regular Market Day High |
0.2051 |
| Regular Market Day Low |
0.172 |
| Regular Market Day Range |
0.172 - 0.2051 |
| Regular Market Open |
0.1903 |
| Regular Market Previous Close |
0.1928 |
| Regular Market Price |
0.1922 |
| Regular Market Time |
1,792,094,400 |
| Regular Market Volume |
857,533 |
| Return On Assets |
-0.65426004 |
| Return On Equity |
-3.4532402 |
| Sand P52 Week Change |
0.16207206 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
19,339,786 |
| Shares Percent Shares Out |
0.070300005 |
| Shares Short |
1,358,824 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
403,121 |
| Short Name |
KALA BIO, Inc. |
| Short Percent Of Float |
0.0706 |
| Short Ratio |
0.37 |
| Source Interval |
15 |
| State |
MA |
| Symbol |
KALA |
| Total Cash |
7,229,000 |
| Total Cash Per Share |
0.374 |
| Total Debt |
0 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-10.71 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
8.503645 |
| Two Hundred Day Average Change |
-8.311445 |
| Two Hundred Day Average Change Percent |
-0.977398 |
| Type Disp |
Equity |
| Volume |
857,533 |
| Website |
https://www.kalarx.com |
| Zip |
2,476 |